Boston Scientific Corporation Free Cash Flow 2007–2025
Boston Scientific Corporation reported $3.66B of free cash flow for fiscal 2025. That was 38.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +223.1%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $3.66B | +38.3% |
| FY 2024 | $2.65B | +47.6% |
| FY 2023 | $1.79B | +91.0% |
| FY 2022 | $938.00M | -28.7% |
| FY 2021 | $1.32B | +16.3% |
| FY 2020 | $1.13B | -17.7% |
| FY 2019 | $1.38B | +23016.7% |
| FY 2018 | $-6.00M | -100.5% |
| FY 2017 | $1.11B | +37.3% |
| FY 2016 | $806.00M | +81.5% |
| FY 2015 | $444.00M | -56.0% |
| FY 2014 | $1.01B | +16.8% |
| FY 2013 | $865.00M | -17.9% |
| FY 2012 | $1.05B | +49.7% |
| FY 2011 | $704.00M | +1228.3% |
| FY 2010 | $53.00M | -89.9% |
| FY 2009 | $523.00M | -38.8% |
| FY 2008 | $854.00M | +49.6% |
| FY 2007 | $571.00M | — |
Source: Boston Scientific Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BSX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Boston Scientific Corporation reported $3.66B of free cash flow for fiscal 2025. That was 38.3% higher than fiscal 2024. Compared with fiscal 2020, the change was +223.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Boston Scientific Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBoston Scientific Corporation — frequently asked questions
What is Boston Scientific Corporation's free cash flow?
Boston Scientific Corporation (BSX) reported free cash flow of $3.66B for fiscal year 2025, per its SEC filings.
How has Boston Scientific Corporation's free cash flow changed over time?
Between fiscal 2007 and 2025, BSX's free cash flow grew at roughly 10.9% per year (compound annual rate), from $571.00M to $3.66B.
Where does this data come from?
Figures are computed from Boston Scientific Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.